Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
A week of learning with MIT Bootcamps sparked ideas that Jal Panchal and Maria Hahn are taking forward to solve problems in health care.
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Measurements could help scientists develop better designs for a bioartificial pancreas.
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.
Device could help insulin-producing cells live longer after transplant and improve treatment of type 1 diabetes.
Engineered insulin that can be activated by high blood sugar could improve diabetics’ quality of life.
Conceived at an MIT hackathon, system could reduce amputations, cut medical costs for diabetics.
New app lets patients work alone or with others to prevent, monitor, and reverse chronic disease.